See more : The Cannabist Company Holdings Inc. (CBST.NE) Income Statement Analysis – Financial Results
Complete financial analysis of IntelliCentrics Global Holdings Ltd. (6819.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of IntelliCentrics Global Holdings Ltd., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Global Lighting Technologies Inc. (4935.TW) Income Statement Analysis – Financial Results
- JM Financial Limited (JMFINANCIL.BO) Income Statement Analysis – Financial Results
- Sanok Rubber Company Spólka Akcyjna (SNK.WA) Income Statement Analysis – Financial Results
- Kismet Acquisition Two Corp. (KAIIU) Income Statement Analysis – Financial Results
- SUDARSHAN PHARMA INDUSTRIES LI (SUDARSHAN.BO) Income Statement Analysis – Financial Results
IntelliCentrics Global Holdings Ltd. (6819.HK)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
About IntelliCentrics Global Holdings Ltd.
IntelliCentrics Global Holdings Ltd., an investment holding company, provides credentialing services in the United States, Canada, Taiwan, and the United Kingdom. It primarily operates a credentialing platform under the SEC?URE name for compliance and security purposes in the healthcare industry. The company's platform collects, processes, and verifies data and information in accordance with the various requirements of locations of care, including hospitals, physician offices, and other types of healthcare locations. It primarily provides vendor credentialing and medical credentialing solutions through its platform, as well as other additional services. As of June 30, 2021, it had 10,232 registered locations of care. The company was formerly known as 31 Frameworks Ltd. and changed its name to IntelliCentrics Global Holdings Ltd. in February 2018. The company was founded in 2007 and is headquartered in Flower Mound, Texas. IntelliCentrics Global Holdings Ltd. is a subsidiary of Ocin Corp.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|
Revenue | 43.98M | 40.69M | 37.67M | 36.08M | 34.04M | 31.40M | 30.83M | 30.14M |
Cost of Revenue | 4.81M | 5.39M | 4.90M | 2.28M | 2.09M | 1.61M | 1.43M | 1.52M |
Gross Profit | 39.17M | 35.31M | 32.77M | 33.81M | 31.95M | 29.79M | 29.41M | 28.62M |
Gross Profit Ratio | 89.07% | 86.76% | 86.99% | 93.70% | 93.86% | 94.89% | 95.37% | 94.97% |
Research & Development | 15.41M | 14.13M | 13.82M | 11.37M | 8.84M | 5.88M | 4.21M | 5.73M |
General & Administrative | 10.59M | 9.74M | 9.72M | 17.77M | 8.43M | 6.43M | 5.04M | 6.03M |
Selling & Marketing | 6.50M | 4.73M | 4.77M | 5.75M | 4.33M | 3.29M | 4.11M | 4.29M |
SG&A | 17.09M | 14.47M | 14.49M | 23.52M | 12.76M | 9.72M | 9.14M | 10.32M |
Other Expenses | -283.00K | -6.33M | -4.00K | 0.00 | 4.70M | 3.53M | 2.09M | 2.82M |
Operating Expenses | 45.02M | 40.20M | 36.65M | 34.89M | 26.30M | 19.13M | 15.44M | 18.87M |
Cost & Expenses | 49.83M | 45.59M | 41.55M | 37.16M | 28.39M | 20.74M | 16.87M | 20.38M |
Interest Income | 518.00K | 95.00K | 1.73M | 716.00K | 856.00K | 813.00K | 188.00K | 52.00K |
Interest Expense | 2.19M | 1.43M | 1.27M | 1.43M | 1.28M | 79.00K | 120.00K | 183.00K |
Depreciation & Amortization | 2.67M | 11.24M | 9.14M | 723.33K | 319.00K | 343.00K | 661.00K | 902.00K |
EBITDA | 2.70M | 303.00K | 5.61M | -1.42M | 7.22M | 10.93M | 15.73M | 10.29M |
EBITDA Ratio | 6.15% | 0.74% | 14.90% | -3.93% | 21.22% | 34.81% | 51.02% | 34.16% |
Operating Income | -6.30M | -4.49M | -4.28M | -1.29M | 6.05M | 9.77M | 13.23M | 8.69M |
Operating Income Ratio | -14.32% | -11.03% | -11.37% | -3.56% | 17.76% | 31.13% | 42.92% | 28.83% |
Total Other Income/Expenses | -2.44M | -7.48M | -915.00K | 4.15M | -28.00K | -153.00K | -313.00K | -1.70M |
Income Before Tax | -8.29M | -12.37M | -4.80M | -2.85M | 5.62M | 10.51M | 13.30M | 8.56M |
Income Before Tax Ratio | -18.85% | -30.40% | -12.74% | -7.89% | 16.51% | 33.47% | 43.14% | 28.40% |
Income Tax Expense | 550.00K | -724.00K | -1.82M | 2.45M | 2.57M | 2.70M | 6.29M | 3.74M |
Net Income | -8.84M | -11.59M | -2.88M | -5.25M | 3.05M | 7.81M | 7.01M | 4.82M |
Net Income Ratio | -20.11% | -28.49% | -7.66% | -14.55% | 8.96% | 24.88% | 22.73% | 15.99% |
EPS | -0.02 | -0.03 | -0.01 | -0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
EPS Diluted | -0.02 | -0.03 | -0.01 | -0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
Weighted Avg Shares Out | 453.00M | 455.00M | 434.72M | 434.34M | 449.47M | 449.47M | 449.47M | 449.47M |
Weighted Avg Shares Out (Dil) | 453.00M | 455.00M | 457.00M | 434.34M | 449.47M | 449.47M | 449.47M | 449.47M |
Source: https://incomestatements.info
Category: Stock Reports